BETH STEWART: Open Payments
NPI 1881001956 · VESTAL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,933 in 96 payments from 16 companies in 2025. Trend: 2023 $1,828 · 2024 $2,160 · 2025 $1,933
Food & beverage: $1,738Education: $195
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $487 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $293 |
| Incyte Corporation | 13 | $289 |
| Novartis Pharmaceuticals Corporation | 14 | $228 |
| Regeneron Healthcare Solutions, Inc. | 5 | $158 |
| GENZYME CORPORATION | 6 | $139 |
| LEO Pharma Inc. | 3 | $62 |
| Janssen Biotech, Inc. | 3 | $58 |
| Novo Nordisk Inc | 2 | $38 |
| PFIZER INC. | 2 | $36 |
Products named: OPZELURA, DUPIXENT, RINVOQ, SKYRIZI, COSENTYX, ILUMYA, ADBRY, TREMFYA.
Industry payments across NY — which companies pay providers there.
